Updated Data from the Phase 1/2 Study of Olomorasib in KRAS G12C-Mutant Advanced Solid Tumors Presented at the 2024 ASCO® Annual MeetingPRNewsWire • 36m
Blue-Chip Bubble Trouble: 7 Stocks to Short as Valuations Stretch to the LimitInvestorPlace • Thursday
Lilly, UNICEF expand support to help millions of young people at risk of noncommunicable diseasesPRNewsWire • Wednesday
Eli Lilly and Company (LLY) Is a Trending Stock: Facts to Know Before Betting on ItZacks Investment Research • Tuesday
Soaring Eli Lilly Stock Could Climb Another 24% According to a Wall Street Analyst. Is the Stock a Buy Now?The Motley Fool • Tuesday
Eli Lilly to invest another $5.3 billion in Indiana plant to expand Mounjaro, Zepbound supplyCNBC • 05/24/24
Lilly Increases Manufacturing Investment to $9 Billion at Newest Indiana Site to Boost API Production for Tirzepatide and Pipeline MedicinesPRNewsWire • 05/24/24
Lilly Announces Details of Presentations at 2024 American Society of Clinical Oncology (ASCO) Annual MeetingPRNewsWire • 05/23/24